LINK . SPRINGER . COM {}

Matching Content Categories {📚}

• Health & Fitness
• Education
• Insurance

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We can't figure out the monetization strategy.

Not every website is profit-driven; some are created to spread information or serve as an online presence. Websites can be made for many reasons. This could be one of them. Link.springer.com could have a money-making trick up its sleeve, but it's undetectable for now.

Keywords {🔍}

cancer, breast, google, scholar, evaluation, serum, tumor, article, markers, patients, director, hospital, research, iwase, kobayashi, itoh, marker, privacy, cookies, treatment, advanced, nagoya, city, content, information, journal, publish, search, recurrent, cea, clinical, access, surg, data, change, log, masaoka, bca, discover, tumour, jpn, carcinoma, download, national, springer, optional, analysis, personal, parties, policy,

Topics {✒️}

serum tumor markers month download article/chapter breast cancer research tumour marker courses serum markers recurrent breast cancer privacy choices/manage cookies breast cancer treatments primary breast cancer metastasising breast cancer tumor markers toyokawa city hospital serum tumor marker circulating ca15-3 levels postoperative cea time breast cancer treatment serological evaluation toyota memorial hospital prognostic factors director hiroshi itoh breast cancer patients full article pdf director tetsuo hotta director kazuo shibata director hironori tanaka director katsumi nakamae european economic area sialyl-sugar residue bca225 concentrations conditions privacy policy tumor marker concentration monoclonal antibody reactive breast cancer breast cancer 7 director shoji karamatsu director koji matsuo accepting optional cookies check access instant access predictive journal finder publish cancer res 75 breast carcinoma cancer treatment cancer patient gastrointestinal cancer serum positivity related subjects tumour shunzo kobayashi

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Evaluation of serum tumor markers in patients with advanced or recurrent breast cancer
         description:Serum CA15-3, CEA, and BCA225 concentrations were determined in 98 patients with advanced or recurrent breast cancer in an attempt to correlate elevation with clinical status. The rate of serum positivity was 68.4% (67/98), 55.1% (54/98), and 43.9% (43/98) for CA15-3, CEA, and BCA225, respectively. After a 4 weeksinterval, a 20% change of tumor marker concentration from the preceding assay correlated significantly with clinical findings. Significant elevation was predictive of new recurrence or tumor regrowth after complete remission, especially in patients with bone metastasis. The 20% change in concentration at 4 weeks was also useful in patients with tumor marker concentrations persistently beneath the cut-off level for positive. Serological evaluation of tumor markers in patients with advanced or recurrent breast cancer should seek to document 20% changes over a 4 week interval.
         datePublished:
         dateModified:
         pageStart:83
         pageEnd:88
         sameAs:https://doi.org/10.1007/BF00666074
         keywords:
            breast cancer
            CA15-3
            CEA
            BCA225
            serological evaluation
            serum markers
            Oncology
         image:
         isPartOf:
            name:Breast Cancer Research and Treatment
            issn:
               1573-7217
               0167-6806
            volumeNumber:33
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Kluwer Academic Publishers
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Hirotaka Iwase
               affiliation:
                     name:Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment
                     address:
                        name:Second Department of Surgery, Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment, Nagoya, Japan
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Shunzo Kobayashi
               affiliation:
                     name:Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment
                     address:
                        name:Second Department of Surgery, Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment, Nagoya, Japan
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Yukashi Itoh
               affiliation:
                     name:Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment
                     address:
                        name:Second Department of Surgery, Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment, Nagoya, Japan
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Hideki Fukuoka
               affiliation:
                     name:Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment
                     address:
                        name:Second Department of Surgery, Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment, Nagoya, Japan
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Tatsuya Kuzushima
               affiliation:
                     name:Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment
                     address:
                        name:Second Department of Surgery, Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment, Nagoya, Japan
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Hiroji Iwata
               affiliation:
                     name:Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment
                     address:
                        name:Second Department of Surgery, Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment, Nagoya, Japan
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Toshinari Yamashita
               affiliation:
                     name:Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment
                     address:
                        name:Second Department of Surgery, Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment, Nagoya, Japan
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Akihiro Naitoh
               affiliation:
                     name:Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment
                     address:
                        name:Second Department of Surgery, Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment, Nagoya, Japan
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Kazuko Itoh
               affiliation:
                     name:Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment
                     address:
                        name:Second Department of Surgery, Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment, Nagoya, Japan
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Akira Masaoka
               affiliation:
                     name:Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment
                     address:
                        name:Second Department of Surgery, Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment, Nagoya, Japan
                        type:PostalAddress
                     type:Organization
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Evaluation of serum tumor markers in patients with advanced or recurrent breast cancer
      description:Serum CA15-3, CEA, and BCA225 concentrations were determined in 98 patients with advanced or recurrent breast cancer in an attempt to correlate elevation with clinical status. The rate of serum positivity was 68.4% (67/98), 55.1% (54/98), and 43.9% (43/98) for CA15-3, CEA, and BCA225, respectively. After a 4 weeksinterval, a 20% change of tumor marker concentration from the preceding assay correlated significantly with clinical findings. Significant elevation was predictive of new recurrence or tumor regrowth after complete remission, especially in patients with bone metastasis. The 20% change in concentration at 4 weeks was also useful in patients with tumor marker concentrations persistently beneath the cut-off level for positive. Serological evaluation of tumor markers in patients with advanced or recurrent breast cancer should seek to document 20% changes over a 4 week interval.
      datePublished:
      dateModified:
      pageStart:83
      pageEnd:88
      sameAs:https://doi.org/10.1007/BF00666074
      keywords:
         breast cancer
         CA15-3
         CEA
         BCA225
         serological evaluation
         serum markers
         Oncology
      image:
      isPartOf:
         name:Breast Cancer Research and Treatment
         issn:
            1573-7217
            0167-6806
         volumeNumber:33
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Kluwer Academic Publishers
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Hirotaka Iwase
            affiliation:
                  name:Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment
                  address:
                     name:Second Department of Surgery, Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment, Nagoya, Japan
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Shunzo Kobayashi
            affiliation:
                  name:Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment
                  address:
                     name:Second Department of Surgery, Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment, Nagoya, Japan
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Yukashi Itoh
            affiliation:
                  name:Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment
                  address:
                     name:Second Department of Surgery, Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment, Nagoya, Japan
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Hideki Fukuoka
            affiliation:
                  name:Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment
                  address:
                     name:Second Department of Surgery, Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment, Nagoya, Japan
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Tatsuya Kuzushima
            affiliation:
                  name:Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment
                  address:
                     name:Second Department of Surgery, Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment, Nagoya, Japan
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Hiroji Iwata
            affiliation:
                  name:Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment
                  address:
                     name:Second Department of Surgery, Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment, Nagoya, Japan
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Toshinari Yamashita
            affiliation:
                  name:Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment
                  address:
                     name:Second Department of Surgery, Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment, Nagoya, Japan
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Akihiro Naitoh
            affiliation:
                  name:Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment
                  address:
                     name:Second Department of Surgery, Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment, Nagoya, Japan
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Kazuko Itoh
            affiliation:
                  name:Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment
                  address:
                     name:Second Department of Surgery, Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment, Nagoya, Japan
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Akira Masaoka
            affiliation:
                  name:Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment
                  address:
                     name:Second Department of Surgery, Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment, Nagoya, Japan
                     type:PostalAddress
                  type:Organization
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:Breast Cancer Research and Treatment
      issn:
         1573-7217
         0167-6806
      volumeNumber:33
Organization:
      name:Kluwer Academic Publishers
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment
      address:
         name:Second Department of Surgery, Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment, Nagoya, Japan
         type:PostalAddress
      name:Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment
      address:
         name:Second Department of Surgery, Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment, Nagoya, Japan
         type:PostalAddress
      name:Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment
      address:
         name:Second Department of Surgery, Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment, Nagoya, Japan
         type:PostalAddress
      name:Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment
      address:
         name:Second Department of Surgery, Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment, Nagoya, Japan
         type:PostalAddress
      name:Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment
      address:
         name:Second Department of Surgery, Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment, Nagoya, Japan
         type:PostalAddress
      name:Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment
      address:
         name:Second Department of Surgery, Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment, Nagoya, Japan
         type:PostalAddress
      name:Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment
      address:
         name:Second Department of Surgery, Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment, Nagoya, Japan
         type:PostalAddress
      name:Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment
      address:
         name:Second Department of Surgery, Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment, Nagoya, Japan
         type:PostalAddress
      name:Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment
      address:
         name:Second Department of Surgery, Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment, Nagoya, Japan
         type:PostalAddress
      name:Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment
      address:
         name:Second Department of Surgery, Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment, Nagoya, Japan
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Hirotaka Iwase
      affiliation:
            name:Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment
            address:
               name:Second Department of Surgery, Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment, Nagoya, Japan
               type:PostalAddress
            type:Organization
      name:Shunzo Kobayashi
      affiliation:
            name:Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment
            address:
               name:Second Department of Surgery, Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment, Nagoya, Japan
               type:PostalAddress
            type:Organization
      name:Yukashi Itoh
      affiliation:
            name:Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment
            address:
               name:Second Department of Surgery, Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment, Nagoya, Japan
               type:PostalAddress
            type:Organization
      name:Hideki Fukuoka
      affiliation:
            name:Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment
            address:
               name:Second Department of Surgery, Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment, Nagoya, Japan
               type:PostalAddress
            type:Organization
      name:Tatsuya Kuzushima
      affiliation:
            name:Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment
            address:
               name:Second Department of Surgery, Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment, Nagoya, Japan
               type:PostalAddress
            type:Organization
      name:Hiroji Iwata
      affiliation:
            name:Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment
            address:
               name:Second Department of Surgery, Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment, Nagoya, Japan
               type:PostalAddress
            type:Organization
      name:Toshinari Yamashita
      affiliation:
            name:Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment
            address:
               name:Second Department of Surgery, Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment, Nagoya, Japan
               type:PostalAddress
            type:Organization
      name:Akihiro Naitoh
      affiliation:
            name:Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment
            address:
               name:Second Department of Surgery, Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment, Nagoya, Japan
               type:PostalAddress
            type:Organization
      name:Kazuko Itoh
      affiliation:
            name:Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment
            address:
               name:Second Department of Surgery, Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment, Nagoya, Japan
               type:PostalAddress
            type:Organization
      name:Akira Masaoka
      affiliation:
            name:Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment
            address:
               name:Second Department of Surgery, Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment, Nagoya, Japan
               type:PostalAddress
            type:Organization
PostalAddress:
      name:Second Department of Surgery, Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment, Nagoya, Japan
      name:Second Department of Surgery, Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment, Nagoya, Japan
      name:Second Department of Surgery, Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment, Nagoya, Japan
      name:Second Department of Surgery, Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment, Nagoya, Japan
      name:Second Department of Surgery, Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment, Nagoya, Japan
      name:Second Department of Surgery, Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment, Nagoya, Japan
      name:Second Department of Surgery, Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment, Nagoya, Japan
      name:Second Department of Surgery, Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment, Nagoya, Japan
      name:Second Department of Surgery, Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment, Nagoya, Japan
      name:Second Department of Surgery, Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment, Nagoya, Japan
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {🔗}(56)

• What's the financial intake of https://www.springernature.com/gp/authors?
• Get to know what's the income of https://link.springernature.com/home/
• How much income does https://order.springer.com/public/cart have?
• What are the earnings of https://submission.springernature.com/new-submission/10549/3?
• How much does https://www.springernature.com/gp/librarians/licensing/agc/journals net monthly?
• How much does http://scholar.google.com/scholar_lookup?&title=Evaluation%20of%20effects%20of%20breast%20cancer%20treatments%20by%20serum%20tumor%20marker&journal=Jpn%20J%20Breast%20Cancer&volume=7&pages=356-365&publication_year=1992&author=Iwase%2CH&author=Kobayashi%2CS generate monthly?
• See how much http://scholar.google.com/scholar_lookup?&title=The%20clinical%20value%20of%20serum%20CA15-3%20assay%20postoperatively%20in%20breast%20cancer%20patients&journal=Jpn%20J%20Surg&volume=19&pages=278-282&publication_year=1989&author=Kobayashi%2CS&author=Iwase%2CH&author=Karamatsu%2CS&author=Matsuo%2CK&author=Masaoka%2CA&author=Miyagawa%2CT makes per month
• How much income does http://scholar.google.com/scholar_lookup?&title=Circulating%20CA15-3%20levels%20in%20the%20postsurgical%20follow-up%20of%20breast%20cancer%20patients%20and%20in%20non-malignant%20diseases&journal=Breast%20Cancer%20Research%20and%20Treatment&volume=13&pages=123-133&publication_year=1989&author=Colomer%2CR&author=Ruibal%2CA&author=Genolla%2CJ&author=Rubio%2CD&author=DelCampo%2CJM&author=Bodi%2CR&author=Salvador%2CL have?
• What's the financial intake of http://scholar.google.com/scholar_lookup?&title=Circulating%20tumor%20marker%20levels%20in%20advanced%20breast%20carcinoma%20correlate%20with%20the%20extent%20of%20metastatic%20disease&journal=Cancer&volume=64&pages=1674-1681&publication_year=1989&author=Colomer%2CR&author=Ruibal%2CA&author=Salvador%2CL?
• How much does http://scholar.google.com/scholar_lookup?&title=The%20tumour%20associated%20antigen%20CA15-3%20in%20primary%20breast%20cancer.%20Evaluation%20of%20667%20cases&journal=Br%20J%20Cancer&volume=63&pages=809-813&publication_year=1991&author=Gion%2CM&author=Mione%2CR&author=Nascimben%2CO&author=Valsecchi%2CM&author=Gatti%2CC&author=Leon%2CA&author=Bruscagnin%2CG make?
• Profit of http://scholar.google.com/scholar_lookup?&title=The%20use%20of%20CA15-3%20as%20a%20serum%20tumor%20marker%20in%20breast%20carcinoma&journal=Eur%20J%20Surg%20Oncol&volume=17&pages=16-19&publication_year=1991&author=Duncan%2CJL&author=Price%2CA&author=Rogers%2CK
• How much does http://scholar.google.com/scholar_lookup?&title=CA15-3%20and%20carcinoembryonic%20antigen%20in%20the%20clinical%20evaluation%20of%20breast%20cancer&journal=Clinica%20Chimica%20Acta&volume=200&pages=81-94&publication_year=1991&author=Dnistrian%2CAM&author=Schwartz%2CMK&author=Greenberg%2CEJ&author=Smith%2CCA&author=Schwartz%2CDC gross monthly?
• What's the monthly money flow for http://scholar.google.com/scholar_lookup?&title=Immunocytochemical%20distribution%20of%20a%20breast%20carcinoma%20associated%20glycoprotein%20identified%20by%20monoclonal%20antibodies&journal=American%20Journal%20of%20Pathology&volume=130&pages=305-314&publication_year=1988&author=Mesa-Tejada%2CR&author=Palakodety%2CRB&author=Leon%2CJA&author=Khatcherian%2CAO&author=Greaton%2CCJ?
• What's http://scholar.google.com/scholar_lookup?&title=Monoclonal%20antibody%20reactive%20with%20the%20sialyl-sugar%20residue%20of%20a%20high%20molecular%20weight%20glycoprotein%20in%20sera%20of%20cancer%20patient&journal=Jpn%20J%20Cancer%20Res&volume=75&pages=485-488&publication_year=1985&author=Hirohashi%2CS&author=Watanabe%2CM&author=Shimosato%2CY's gross income?
• How much does http://scholar.google.com/scholar_lookup?&title=Tumour%20Marker%20Courses%20to%20assess%20the%20efficacy%20of%20chemotherapy%20or%20hormone%20therapy%20in%20metastasising%20breast%20cancer&journal=Geburtsh%20u%20Frauenheilk&volume=53&pages=24-29&publication_year=1993&author=Mobus%2CV&author=Paula%2CJ&author=Beck%2CT&author=Crombach%2CG&author=Kreienberg%2CR generate monthly?
• http://scholar.google.com/scholar_lookup?&title=Evaluation%20of%20cancer%20treatment%20by%20serum%20markers&journal=J%20Clin%20Surg&volume=47&pages=6231-628&publication_year=1992&author=Ohkura%2CH&author=Sugano%2CY&author=Shimada%2CY&author=Saitou%2CD&author=Shirao%2CK&author=Okazaki%2CN&author=Okada%2CS&author=Yoshimori%2CM's financial summary
• Check the income stats for http://scholar.google.com/scholar_lookup?&title=Slope%20analysis%20of%20the%20postoperative%20CEA%20time%20course%20and%20possible%20application%20as%20an%20aid%20in%20diagnosis%20of%20disease%20progression%20in%20gastrointestinal%20cancer&journal=Am%20J%20Surg&volume=136&pages=322-327&publication_year=1978&author=Staab%2CHJ
• How much cash flow does https://citation-needed.springer.com/v2/references/10.1007/BF00666074?format=refman&flavour=references have monthly?
• How much cash flow does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Hirotaka%20Iwase have monthly?
• What's the financial gain of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Hirotaka%20Iwase%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
• How much profit is https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Shunzo%20Kobayashi making per month?
• How much revenue does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Shunzo%20Kobayashi%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en generate?
• https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Yukashi%20Itoh's financial summary
• Monthly income for https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Yukashi%20Itoh%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
• What's the financial intake of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Hideki%20Fukuoka?
• How much revenue does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Hideki%20Fukuoka%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en produce monthly?
• Monthly income for https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Tatsuya%20Kuzushima
• Earnings of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Tatsuya%20Kuzushima%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
• Explore the financials of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Hiroji%20Iwata
• How much does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Hiroji%20Iwata%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en pull in monthly?
• Discover the revenue of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Toshinari%20Yamashita
• Explore the financials of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Toshinari%20Yamashita%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
• How much does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Akihiro%20Naitoh generate monthly?
• Revenue of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Akihiro%20Naitoh%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
• What's the financial intake of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Kazuko%20Itoh?
• https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Kazuko%20Itoh%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en's financial summary
• How much does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Akira%20Masaoka bring in each month?
• What's the income of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Akira%20Masaoka%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
• What's the total monthly financial gain of https://s100.copyright.com/AppDispatchServlet?title=Evaluation%20of%20serum%20tumor%20markers%20in%20patients%20with%20advanced%20or%20recurrent%20breast%20cancer&author=Hirotaka%20Iwase%20et%20al&contentID=10.1007%2FBF00666074©right=Kluwer%20Academic%20Publishers&publication=0167-6806&publicationDate=1995-01&publisherName=SpringerNature&orderBeanReset=true?
• How much revenue does https://citation-needed.springer.com/v2/references/10.1007/BF00666074?format=refman&flavour=citation generate?
• Income figures for https://authorservices.springernature.com/go/sn/?utm_source=SNLinkfooter&utm_medium=Web&utm_campaign=SNReferral
• How much money does https://www.springernature.com/gp/open-research/about/the-fundamentals-of-open-access-and-open-research make?
• What's the profit of https://www.springernature.com/gp/products?
• See how much https://www.springernature.com/gp/librarians makes per month
• How much revenue does https://www.springernature.com/gp/societies produce monthly?
• What's the income generated by https://www.springernature.com/gp/partners each month?
• How much income does https://www.springer.com/ have?
• Income figures for https://www.nature.com/
• What's the financial gain of https://www.biomedcentral.com/?
• How much cash flow does https://www.palgrave.com/ have monthly?
• How much does https://www.apress.com/ gross monthly?
• What's https://www.springernature.com/gp/legal/ccpa's gross income?
• How much profit is https://www.springernature.com/gp/info/accessibility making per month?
• How much revenue does https://support.springernature.com/en/support/home produce monthly?
• How much revenue does https://support.springernature.com/en/support/solutions/articles/6000255911-subscription-cancellations bring in?
• What is the earnings of https://www.springernature.com/?

Analytics and Tracking {📊}

• Google Tag Manager

Libraries {📚}

• Clipboard.js
• Prism.js

CDN Services {📦}

• Crossref